Table 2.
Comparison of different rodent models of NAFLD.
| Obesity | Insulin resistance | Steatosis | Fibrosis | NASH | |
|---|---|---|---|---|---|
| Dietary models | |||||
| MCD | No | Hepatic IR only | Yes | Yes | Yes | 
| CDAA | No | No | Yes | Yes | Yes | 
| HFD | Yes | Yes | Yes | No | No | 
| HFHS (inc. fructose/glucose/sucrose) | Yes | Yes | Yes | Some | Some | 
| Chemical/pharmacological | |||||
| STZ + HFD | Yes | Yes | Yes | Yes | Yes | 
| CCL4 | No | No | Yes | Yes | Yes | 
| Paracetamol | No | No | Yes | Yes | Yes | 
| Genetic models | |||||
| ob/ob mice | Yes | Yes | Yes | No | No | 
| db/db mice | Yes | Yes | Yes | No | No | 
| PTEN knockout mice | No | No | Yes | Yes | Yes | 
| SREBP-1c transgenic mice | Weight loss | Yes | Yes | Yes | Yes | 
| KK-Ay/a mice | Yes | Yes | Yes | No | No | 
| PPAR-α knockout mice | No | No | Yes | No | No | 
| AOX knockout mice | No | No | Yes | No | Yes (transient) | 
| CD36 knockout mice | No | Hepatic IR only | Yes | No | Yes | 
| ApoE knockout mice | No | No | Yes | No | No |